Fred Racine

1.1k total citations
12 papers, 479 citations indexed

About

Fred Racine is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Fred Racine has authored 12 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Fred Racine's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Fred Racine is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Fred Racine collaborates with scholars based in United States. Fred Racine's co-authors include Mary Motyl, Nicholas Murgolo, Lorraine D. Hernandez, Alex G. Therien, Katherine Young, Edward DiNunzio, Payal R. Sheth, Li Xiao, R.A. Giacobbe and Jennifer Nielsen Kahn and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Fred Racine

12 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Racine United States 9 254 179 166 164 80 12 479
Joanne Carroll United States 10 132 0.5× 136 0.8× 82 0.5× 456 2.8× 34 0.4× 15 601
Zrinka Ivezic‐Schoenfeld United States 9 202 0.8× 69 0.4× 69 0.4× 107 0.7× 82 1.0× 14 445
Chiara Sepulcri Italy 10 234 0.9× 163 0.9× 91 0.5× 114 0.7× 16 0.2× 26 408
Omid Pajand Iran 11 80 0.3× 98 0.5× 51 0.3× 304 1.9× 19 0.2× 25 418
Christine Fregeau United States 8 130 0.5× 119 0.7× 169 1.0× 137 0.8× 12 0.1× 8 315
Jennifer I. Smart United States 11 185 0.7× 102 0.6× 112 0.7× 76 0.5× 18 0.2× 28 366
Tetsuo Yamaguchi Japan 14 302 1.2× 109 0.6× 33 0.2× 107 0.7× 19 0.2× 45 501
Lori Banks United States 9 118 0.5× 104 0.6× 70 0.4× 150 0.9× 63 0.8× 11 440
Sara K. Olofsson Sweden 6 50 0.2× 93 0.5× 249 1.5× 236 1.4× 15 0.2× 8 442
Wenjian Liao China 13 148 0.6× 102 0.6× 80 0.5× 323 2.0× 11 0.1× 23 534

Countries citing papers authored by Fred Racine

Since Specialization
Citations

This map shows the geographic impact of Fred Racine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Racine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Racine more than expected).

Fields of papers citing papers by Fred Racine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Racine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Racine. The network helps show where Fred Racine may publish in the future.

Co-authorship network of co-authors of Fred Racine

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Racine. A scholar is included among the top collaborators of Fred Racine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Racine. Fred Racine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Carr, Donna, Huong Trinh, Fred Racine, et al.. (2022). Development of a fully automated platform for agar-based measurement of viable bacterial growth. SLAS TECHNOLOGY. 27(4). 247–252. 1 indexed citations
2.
Carr, Donna, Zufei Zhang, Qian Si, et al.. (2020). In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant Pseudomonas Aeruginosa. Open Forum Infectious Diseases. 7(11). ofaa469–ofaa469. 3 indexed citations
3.
Young, Katherine, Ronald E. Painter, Susan L. Raghoobar, et al.. (2019). In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa. BMC Microbiology. 19(1). 150–150. 84 indexed citations
4.
Zhang, Zufei, Fred Racine, Donna Carr, et al.. (2019). A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactam. International Journal of Infectious Diseases. 89. 55–61. 35 indexed citations
5.
Wu, Jin, Fred Racine, Michael K. Wismer, et al.. (2018). Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 62(5). 46 indexed citations
6.
Hernandez, Lorraine D., Heather K. Kroh, Edward J. Hsieh, et al.. (2017). Epitopes and Mechanism of Action of the Clostridium difficile Toxin A-Neutralizing Antibody Actoxumab. Journal of Molecular Biology. 429(7). 1030–1044. 33 indexed citations
7.
Orth, Peter, Li Xiao, Lorraine D. Hernandez, et al.. (2014). Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography. Journal of Biological Chemistry. 289(26). 18008–18021. 109 indexed citations
8.
Hernandez, Lorraine D., Fred Racine, Li Xiao, et al.. (2014). Broad Coverage of Genetically Diverse Strains of Clostridium difficile by Actoxumab and Bezlotoxumab Predicted by In Vitro Neutralization and Epitope Modeling. Antimicrobial Agents and Chemotherapy. 59(2). 1052–1060. 40 indexed citations
9.
Hernandez, Lorraine D., Amy Flattery, Susanne Krämer, et al.. (2014). Toxin-Mediated Paracellular Transport of Antitoxin Antibodies Facilitates Protection against Clostridium difficile Infection. Infection and Immunity. 83(1). 405–416. 40 indexed citations
10.
Heasley, Brian, Gregory J. Pacofsky, Ahmed Mamai, et al.. (2012). Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase. Bioorganic & Medicinal Chemistry Letters. 22(22). 6811–6816. 28 indexed citations
11.
Wang, Liangsu, et al.. (2008). Development of an integrated semi-automated system for in vitro pharmacodynamic modelling. Journal of Antimicrobial Chemotherapy. 62(5). 1070–1077. 7 indexed citations
12.
Kahn, Jennifer Nielsen, Ming‐Jo Hsu, Fred Racine, R.A. Giacobbe, & Mary Motyl. (2006). Caspofungin Susceptibility in Aspergillus and Non- Aspergillus Molds: Inhibition of Glucan Synthase and Reduction of β- d -1,3 Glucan Levels in Culture. Antimicrobial Agents and Chemotherapy. 50(6). 2214–2216. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026